| CTSL2 |
CTSL2, CATL2, UNQ268/PRO305, CTSU, CTSV: Cathepsin L2 precursor |
CST5 |
CST5: Cystatin-D precursor |
0.307 |
Evidence |
|
| CTSL2 |
CTSL2, CATL2, UNQ268/PRO305, CTSU, CTSV: Cathepsin L2 precursor |
HRG |
HRG: Histidine-rich glycoprotein precursor |
0.307 |
Evidence |
|
| CTSL2 |
CTSL2, CATL2, UNQ268/PRO305, CTSU, CTSV: Cathepsin L2 precursor |
AHSG |
AHSG, FETUA, PRO2743: Alpha-2-HS-glycoprotein precursor |
0.307 |
Evidence |
|
| CTSL2 |
CTSL2, CATL2, UNQ268/PRO305, CTSU, CTSV: Cathepsin L2 precursor |
CST3 |
CST3: Cystatin-C precursor |
0.307 |
Evidence |
|
| PCDH7 |
PCDH7, BHPCDH: Protocadherin-7 precursor |
AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
0.307 |
Evidence |
|
| UTX |
UTX: Ubiquitously transcribed X chromosome tetratricopeptide repeat protein |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
0.307 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
0.307 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
0.307 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
0.307 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
0.307 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
0.307 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.307 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
0.307 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
0.307 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
OXTR |
OXTR: Oxytocin receptor |
0.307 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
0.307 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
0.307 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
0.307 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
0.307 |
Evidence |
|
| TXNDC |
TXNDC1, TMX, PSEC0085, TXNDC, UNQ235/PRO268: Thioredoxin domain-containing prote |
FUBP1 |
IPI00375441 |
0.307 |
Evidence |
|
| SUZ12 |
SUZ12, CHET9, JJAZ1, KIAA0160: Polycomb protein SUZ12 |
SFRS14 |
SFRS14, KIAA0365: Putative splicing factor, arginine/serine-rich 14 |
0.307 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
CRLF3 |
IPI00295387 |
0.307 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
SORL1 |
SORL1: Sortilin-related receptor precursor |
0.307 |
Evidence |
|
| FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
FKBP10 |
FKBP10, FKBP65, PSEC0056: FK506-binding protein 10 precursor |
0.307 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
CRLF3 |
IPI00295387 |
0.307 |
Evidence |
|